Abstract

We previously characterized a Na+/H+exchange activity in rat pancreatic zymogen granules [Anderie, I., and Thévenod, F. (1996)J. Membrane Biol.152, 195-205]. Here we have identified the Na+/H+exchanger (NHE) isoforms present in zymogen granules by functional studies with NHE inhibitors. The NHE1 specific blocker HOE 694 [3-(methylsulfonyl-4-piperidino-benzoyl)-guanidine methanesulfonate] inhibited zymogen granule Na+/H+exchange in a concentration dependent manner, maximally to 53 ± 5% of controls at 100nM. The remaining Na+/H+exchange activity was inhibitable by EIPA [5-(N-ethyl-N-isopropyl)amiloride] (EC50∼ 25μM) or benzamil (EC50∼ 100μM). Amiloride inhibited weakly suggesting that “amiloride-resistant” and “amiloride-sensitive” NHE are expressed in zymogen granules. cDNA sequences encoding NHE1- and NHE4-specific transmembrane domains were detected by RT-PCR in rat pancreatic tissue and in the rat pancreatic acinar cell line AR4-2J. The presence of NHE1 and NHE4 in zymogen granule membranes was confirmed by immunoblots of zymogen granule membranes and by pre-embedding immunogold labeling of purified rat pancreatic zymogen granules with polyclonal NHE1 and NHE4 antibodies. Therefore, we propose that NHE1 and NHE4 are expressed in zymogen granule membranes of rat exocrine pancreas.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.